Combination Chemotherapy of Intermediate and High- Grade Non-Hodgkin's Lymphoma with m-BACOD
Publication Information Expand/Collapse
1994
African americans treated on SWOG NHL studies: Similar incidence, received dose intensity and outcome to caucasian patients.
1993
A predictive model for aggressive non-Hodgkin's lymphoma. THE INTERNATIONAL NON-HODGKIN'S LYMPHOMA PROGNOSTIC FACTORS PROJECT.
1992
Development of a predictive model for aggressive lymphoma. The International NHL prognostic factors project.
1990
M-BACOD treatment for intermediate and high grade malignant lymphomas: A Southwest Oncology Group phase II trial.
Dose intensity is not associated with subsequent survival after adjustment for known prognostic factors in non-Hodgkin's lymphoma patients treated with m-BACOD, ProMace-CytaBOM, and MACOP-B on Southwest Oncology Group study.
1989
The treatment of non-hodgkin's lymphoma with m-BACOB,ProMACE-CytaBOM, and MACOP-B: The Southwest Oncology Group (SWOG)experience.
1988
Southwest Oncology Group clinical trials for intermediate andhigh grade non-hodgkin's lymphomas.
1987
Southwest Oncology Group clinical trials for intermediate andhigh-grade non-hodgkin's lymphomas.
A phase II study of m-BACOD for intermediate and high grademalignant lymphomas (NHL).